Buphenyl Powder
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with meals to help your body absorb it properly. Before using, shake the container well. If you're using the powder form, mix it with a liquid or soft food, and use only the scoop that comes with the powder to measure the correct dose.
If you mix the powder with food, take the dose immediately and do not store it for later use. However, if you mix it with water, you can store it at room temperature or in the refrigerator for up to 1 week. For individuals with feeding tubes, follow the instructions provided by your healthcare provider and flush the feeding tube after administering the medication.
Storing and Disposing of Your Medication
Keep your medication at room temperature in a dry place, avoiding storage in a bathroom. Ensure the lid is tightly closed when not in use. Store all medications in a safe location, out of the reach of children and pets, to prevent accidental ingestion.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember, with a meal. However, if it's close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time or take extra doses, as this can increase the risk of side effects.
Lifestyle & Tips
- Strict adherence to a low-protein diet as prescribed by your doctor or dietitian is crucial for the effectiveness of this medication.
- Do not stop taking this medication without consulting your doctor, even if you feel well.
- Ensure adequate hydration.
- Follow all dietary and fluid restrictions as advised by your healthcare team.
Available Forms & Alternatives
Available Strengths:
Generic Alternatives:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, contact your doctor or seek medical help right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of acidosis (too much acid in the blood), such as:
+ Confusion
+ Fast breathing
+ Fast heartbeat
+ Irregular heartbeat
+ Severe stomach pain, nausea, or vomiting
+ Excessive sleepiness
+ Shortness of breath
+ Feeling extremely tired or weak
Signs of electrolyte problems, such as:
+ Mood changes
+ Confusion
+ Muscle pain, cramps, or spasms
+ Weakness
+ Shakiness
+ Balance problems
+ Abnormal heartbeat
+ Seizures
+ Loss of appetite
+ Severe nausea or vomiting
Feeling extremely tired or weak
Dizziness or headache
Nausea or vomiting
Excessive sleepiness
Confusion
Changes in hearing
Memory problems or loss
Abnormal burning, numbness, or tingling sensations
Swelling
Other Possible Side Effects
Like all medications, this drug can cause side effects. However, many people do not experience any side effects or only have mild ones. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical help:
Decreased appetite
Bad taste in your mouth
Changes in body odor
Menstrual changes or irregular periods
Reporting Side Effects
This is not an exhaustive list of all possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Unusual tiredness or lethargy
- Irritability or changes in behavior
- Vomiting or poor feeding (especially in infants)
- Confusion or disorientation
- Slurred speech
- Unsteady gait (ataxia)
- Seizures
- Loss of consciousness (these are signs of high ammonia levels and require immediate medical attention)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking any of the following medications: divalproex, haloperidol, or valproic acid. Please note that this is not an exhaustive list of interacting drugs, and it is crucial to discuss all your medications with your doctor.
All your current medications, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions and ensure safe treatment.
Any existing health problems, as they may affect the safety and efficacy of this medication.
Remember, before starting, stopping, or changing the dose of any medication, including this one, you must consult with your doctor to confirm it is safe to do so. This precaution will help prevent potential interactions and ensure your treatment plan is optimized for your specific needs.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Somnolence
- Fatigue
- Headache
- Nausea
- Vomiting
- Abdominal discomfort
- Metabolic acidosis
- Hypernatremia (due to sodium content)
What to Do:
In case of suspected overdose, seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222). Management is supportive and may include discontinuation of the drug, correction of metabolic acidosis and hypernatremia, and potentially hemodialysis in severe cases.
Drug Interactions
Moderate Interactions
- Valproic acid
- Corticosteroids
- Probenecid
Monitoring
Baseline Monitoring
Rationale: To establish baseline and guide initial dosing.
Timing: Prior to initiation of therapy.
Rationale: To assess the effectiveness of nitrogen scavenging.
Timing: Prior to initiation of therapy.
Rationale: To monitor for nutritional deficiencies.
Timing: Prior to initiation of therapy.
Rationale: To monitor for metabolic acidosis, a potential side effect.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline hepatic function.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline renal function, as metabolites are renally excreted.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Weekly initially, then monthly or as clinically indicated.
Target: Within normal or acceptable range for age.
Action Threshold: Persistent elevation above target range requires dose adjustment or re-evaluation of therapy.
Frequency: Monthly or as clinically indicated.
Target: Within normal or acceptable range.
Action Threshold: Persistent elevation indicates inadequate nitrogen scavenging.
Frequency: Monthly or as clinically indicated.
Target: Normal range.
Action Threshold: Development of metabolic acidosis requires intervention.
Frequency: Regularly (e.g., quarterly or at each clinic visit) in pediatric patients.
Target: Appropriate for age and sex.
Action Threshold: Growth faltering may indicate inadequate metabolic control or nutritional deficiency.
Frequency: Every 6-12 months or as clinically indicated.
Target: Normal range.
Action Threshold: Significant abnormalities require investigation and potential dose adjustment.
Symptom Monitoring
- Lethargy
- Irritability
- Vomiting
- Poor feeding
- Ataxia
- Seizures
- Coma (signs of hyperammonemia)
- Unusual fatigue
- Shortness of breath (signs of metabolic acidosis)
Special Patient Groups
Pregnancy
Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Urea cycle disorders can worsen during pregnancy, posing risks to both mother and fetus. Close monitoring of ammonia levels is essential.
Trimester-Specific Risks:
Lactation
It is not known whether sodium phenylbutyrate or its metabolites are excreted in human milk. Due to the potential for serious adverse reactions in the nursing infant, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Sodium phenylbutyrate is primarily used in pediatric patients with urea cycle disorders. Dosing is weight or body surface area-based and highly individualized. Close monitoring of growth, development, and nutritional status is crucial.
Geriatric Use
Clinical studies of Buphenyl did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Clinical Information
Clinical Pearls
- Sodium phenylbutyrate is a cornerstone therapy for urea cycle disorders, but strict dietary protein restriction is equally critical for effective management.
- The powder form can be mixed with food (e.g., applesauce, pudding) or liquid (e.g., water, formula) to improve palatability. Do not mix with acidic liquids.
- Dosing is highly individualized and requires frequent monitoring of plasma ammonia, glutamine, and amino acid levels.
- Patients and caregivers must be educated on the signs and symptoms of hyperammonemia and the importance of immediate medical attention if they occur.
- Due to its sodium content, monitor for hypernatremia, especially in infants or patients with renal impairment.
- Consider the use of glycerol phenylbutyrate (Ravicti) as an alternative, which may offer different pharmacokinetic properties and dosing convenience for some patients.
Alternative Therapies
- Glycerol phenylbutyrate (Ravicti)
- Arginine (for Argininosuccinic Aciduria and Citrullinemia)
- Citrulline (for OTC Deficiency and Carbamyl Phosphate Synthetase Deficiency)
- Carglumic acid (Carbaglu - for N-acetylglutamate synthase deficiency)
- Dietary protein restriction
- Ammonia scavenger medications (e.g., sodium benzoate, sodium phenylacetate)